Find your path to Fernando
271 people in our graph share verified history with Fernando — schools, employers, funds. One of them is your warm intro.
About
Fernando Alarcon is the co-founder and CEO of Ilico Genetics, a company developing a methylated-DNA liquid biopsy to detect gastric cancer early from a blood draw in high-risk patients, such as those with intestinal metaplasia and atrophic gastritis. The company holds an exclusive license from Pontificia Universidad Católica de Chile, has raised over $1 million, won the Judge's Choice and Audience awards at Ben Franklin Venture Idol 2024, and has begun early engagement with the FDA. Prior to Ilico, Alarcon worked in corporate finance and M&A advisory across Latin America, including valuations, capital raises, and growth strategy in the healthcare and pharmaceutical sectors.
MBA at Ilico Genetics
Intro paths
In turn, Fernando can intro founders to Ilico Genetics's investors below.
Ilico Genetics's investors · 1
Co-founders at Ilico Genetics
Experience
- Ilico GeneticsCo-founder & CEOcurrent2019 — present
- ATRUS AdvisorsPartner2019 — 2022Greater Philadelphia Area
- Sitka AdvisorsCorporate Finance Consultant2015 — 2019Chile
- Colliers International | ChileCorporate Finance Consultant2013 — 2015Chile
- TuDiseñoCo-Founder2010 — 2013Santiago, Chile
- Universidad de los AndesTeaching Assistant2011 — 2012Santiago, Chile
- Universidad de los AndesTeaching Assistant2010 — 2011Santiago, Chile
- EntelBusiness Intern2011 — 2012Santiago, Chile
- Whitetail Ski ResortSki Instructor2010 — 2011Pennsylvania, United States
Skills & more
+12 more
MarketingBusiness DevelopmentMarket ResearchMarketing ManagementVenture CapitalAccountingBudgetingValuation ModelingEBITDALBOFusiones y adquisicionesElaboración de modelos financierosLanguages English · Portuguese · Spanish
- Business and Financial Modeling Specialization — University Of Pennsyvania
- Wharton Business and Financial Modeling Capstone — University Of Pennsyvania
- Fundamentals of Quantitative Modeling — University Of Pennsyvania
- Introduction to Spreadsheets and Models — University Of Pennsyvania
- Modeling Risk and Realities — University Of Pennsyvania
- Decision-Making and Scenarios — University Of Pennsyvania
- ASA 114 - Cruising Catamaran — American Sailing
From Fernando's professional profile.
Frequently asked questions
- Who is Fernando Alarcon?
- Fernando Alarcon is the co-founder and CEO of Ilico Genetics, a company developing a methylated-DNA liquid biopsy to detect gastric cancer early from a blood draw in high-risk patients, such as those with intestinal metaplasia and atrophic gastritis. The company holds an exclusive license from Pontificia Universidad Católica de Chile, has raised over $1 million, won the Judge's Choice and Audience awards at Ben Franklin Venture Idol 2024, and has begun early engagement with the FDA. Prior to Ilico, Alarcon worked in corporate finance and M&A advisory across Latin America, including valuations, capital raises, and growth strategy in the healthcare and pharmaceutical sectors.
- Where does Fernando Alarcon work?
- Fernando Alarcon is MBA at Ilico Genetics.
- Where did Fernando Alarcon go to school?
- Fernando Alarcon studied at Villanova University (Master of Business Administration - MBA); Universidad de los Andes (CL) (Bachelor’s Degree, Business Administration); The Wharton School (Specialization, Business and Financial Modeling).
Same school
Also attended Villanova University218
+ 212 more
Also attended Universidad de los Andes (CL)18
+ 12 more
Also attended The Wharton School2,000
+ 1,994 more
Shared employers
Also worked at Ilico Genetics1
Also worked at Colliers International | Chile38
+ 32 more
Also worked at Universidad de los Andes8
+ 2 more




































